Cargando…
Vitamin C supplementation lowers advanced glycation end products (AGEs) and malondialdehyde (MDA) in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled clinical trial
This study evaluated how daily vitamin C administration impacts systemic oxidative stress and inflammation and its safety in T2D patients. This randomized, double‐blinded, placebo‐controlled, parallel‐arm clinical trial included 70 patients with T2D. They were allocated to receive either 500 mg/day...
Autores principales: | Rabizadeh, Soghra, Heidari, Firouzeh, Karimi, Reza, Rajab, Armin, Rahimi‐Dehgolan, Shahram, Yadegar, Amirhossein, Mohammadi, Fatemeh, Mirmiranpour, Hossein, Esteghamati, Alireza, Nakhjavani, Manouchehr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563761/ https://www.ncbi.nlm.nih.gov/pubmed/37823170 http://dx.doi.org/10.1002/fsn3.3530 |
Ejemplares similares
-
Lipid profile, ox‐LDL, and LCAT activity in patients with endometrial carcinoma and type 2 diabetes: The effect of concurrent disease based on a case–control study
por: Qahremani, Reihane, et al.
Publicado: (2023) -
The lack of association between different LDL‐C levels and oxidized LDL in patients with type 2 diabetes
por: Rabizadeh, Soghra, et al.
Publicado: (2023) -
Therapeutic effects of resveratrol and Omega-3 in mice atherosclerosis: focus on histopathological changes
por: Mosavi, Shamsi Sadat, et al.
Publicado: (2023) -
Improvement in Redox Homeostasis after Cytoreductive Surgery in Colorectal Adenocarcinoma
por: Salehi, Salome Sadat, et al.
Publicado: (2021) -
Decreasing trend of blood lipid profile in type 2 diabetes: Not a promising change in HDL-C, a serial cross-sectional study
por: Yadegar, Amirhossein, et al.
Publicado: (2023)